Invention Grant
- Patent Title: Pharmaceutical composition
-
Application No.: US16334144Application Date: 2017-09-18
-
Publication No.: US10792256B2Publication Date: 2020-10-06
- Inventor: Stuart Corr , Timothy James Noakes
- Applicant: MEXICHEM FLUOR S.A. DE C.V.
- Applicant Address: MX San Luis Potosi S.L.P.
- Assignee: MEXICHEM FLUOR S.A. DE C.V.
- Current Assignee: MEXICHEM FLUOR S.A. DE C.V.
- Current Assignee Address: MX San Luis Potosi S.L.P.
- Agency: Brinks Gilson & Llione
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@2d82e3bd com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@c92c266
- International Application: PCT/GB2017/052764 WO 20170918
- International Announcement: WO2018/051133 WO 20180322
- Main IPC: A61K31/137
- IPC: A61K31/137 ; A61K9/00 ; A61K9/12 ; A61K31/439 ; A61K31/573 ; A61K47/14 ; A61K47/24 ; A61K47/32 ; A61K31/56 ; A61K45/06 ; A61P11/00
Abstract:
A pharmaceutical composition is described. The composition comprises: (i) a drug component comprising at least one salmeterol compound selected from salmeterol and the pharmaceutically acceptable derivatives thereof; and (ii) a propellant component comprising 1,1-difluoroethane (HFA-152a).
Public/Granted literature
- US20190274973A1 PHARMACEUTICAL COMPOSITION Public/Granted day:2019-09-12
Information query
